Novartis to manufacture anti-cholesterol drug Leqvio for US in Austria due to delay in US clearance Read more
Sales of long-acting immunosuppressants for non-infectious uveitis to touch $357 mn by 2029: GlobalData Read more
We will look at further expanding our footprint in India by relying on innovative new products Read more
Opportunities remain to address unmet needs in cystic fibrosis therapeutics market: GlobalData Read more